{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:50:29Z","timestamp":1790257829558,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CALABR22G0"],"award-info":[{"award-number":["CALABR22G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Affairs Office of Research & Development","award":["BLR&D BX005301"],"award-info":[{"award-number":["BLR&D BX005301"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL161048"],"award-info":[{"award-number":["R01-HL161048"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parker Institute for Cancer Immunotherapy at UCSF","award":["C-03171"],"award-info":[{"award-number":["C-03171"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK063720"],"award-info":[{"award-number":["P30 DK063720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["S10 1S10OD026940-01"],"award-info":[{"award-number":["S10 1S10OD026940-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung transplantation prolongs survival for many patients with end-stage lung diseases, though long-term outcomes are limited due to allograft inflammation leading to chronic rejection. In this study, we aimed to identify the role of natural killer (NK) cell receptors in lung transplant recipient outcomes. We hypothesized that cystic fibrosis (CF) may be a model for systemic inflammation. Peripheral blood mononuclear cells were collected from recipients with CF (n\u2009=\u20096), recipients with chronic obstructive pulmonary disease (n\u2009=\u20096), and healthy donors (n\u2009=\u20097) for NK cell immunophenotyping via spectral flow cytometry and functional killing assays. Plasma B7H6 was also measured in 2 independent lung transplant cohorts to test the association with rejection. We identified a CF-specific reduction in NKp30 receptor expression, validated functionally against cells expressing the B7H6 ligand. The NKp30 reduction was not NK cell subset specific, suggesting a systemic influence. Further, we found that B7H6 in vitro reduced NKp30-mediated killing of target cells in a dose-dependent fashion. Analysis of soluble B7H6 concentrations in plasma revealed higher soluble B7H6 in CF recipients relative to other groups, suggesting a potentially broader role of soluble B7H6 in lung transplant outcomes. Consequently, B7H6 was higher in recipients without acute graft dysfunction, and higher B7H6 plasma concentrations conferred reduced risk of chronic lung allograft dysfunction (CLAD) and mortality. Single-cell RNA sequencing showed that B7H6 transcripts were most prevalent on ciliated airway epithelial cells and bronchoalveolar lavage monocytes and that airway B7H6 transcripts were reduced in CLAD. Thus, our data reveal a new role of the NKp30\u2013B7H6 axis in potentiating lung allograft outcomes.<\/jats:p>","DOI":"10.1093\/ajrcmb\/aanag017","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:46:21Z","timestamp":1770209181000},"page":"741-754","source":"Crossref","is-referenced-by-count":1,"title":["Circulating B7H6 is associated with reduced NKp30 receptor expression and improved lung transplant recipient survival"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-7155","authenticated-orcid":false,"given":"Avishai","family":"Shemesh","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]},{"name":"Medical Service, VA Health Care System , San Francisco, CA,","place":["United States"]},{"name":"Parker Institute for Cancer Immunotherapy , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenrae","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-8451","authenticated-orcid":false,"given":"Steven R","family":"Hays","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P","family":"Singer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Greenland","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]},{"name":"Medical Service, VA Health Care System , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-3434","authenticated-orcid":false,"given":"Daniel R","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA,","place":["United States"]},{"name":"Medical Service, VA Health Care System , San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"2026060306164300700_aanag017-B1","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.healun.2025.04.014","article-title":"The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: 2025 annual report of heart and lung transplantation","volume":"44","author":"Singh","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B2","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.1016\/j.ajt.2023.02.009","article-title":"OPTN\/SRTR 2021 annual data report: lung","volume":"23","author":"Valapour","year":"2023","journal-title":"Am J Transplant"},{"key":"2026060306164300700_aanag017-B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.thorsurg.2021.11.004","article-title":"Chronic lung allograft dysfunction","volume":"32","author":"Venado","year":"2022","journal-title":"Thorac Surg Clin"},{"key":"2026060306164300700_aanag017-B4","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"2026060306164300700_aanag017-B5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/thoraxjnl-2018-212345","article-title":"Natural killer cells in lung transplantation","volume":"74","author":"Calabrese","year":"2019","journal-title":"Thorax"},{"key":"2026060306164300700_aanag017-B6","doi-asserted-by":"publisher","first-page":"e137047","DOI":"10.1172\/JCI137047","article-title":"Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury","volume":"131","author":"Calabrese","year":"2021","journal-title":"J Clin Invest"},{"key":"2026060306164300700_aanag017-B7","doi-asserted-by":"publisher","first-page":"e173716","DOI":"10.1172\/jci.insight.173716","article-title":"CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury","volume":"8","author":"Santos","year":"2023","journal-title":"JCI Insight"},{"key":"2026060306164300700_aanag017-B8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1189\/jlb.4MA0815-376RR","article-title":"CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection","volume":"99","author":"Lehmann","year":"2016","journal-title":"J Leukoc Biol"},{"key":"2026060306164300700_aanag017-B9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121291","article-title":"PARP-1 controls NK cell recruitment to the site of viral infection","volume":"4","author":"Shou","year":"2019","journal-title":"JCI Insight"},{"key":"2026060306164300700_aanag017-B10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/ni1523","article-title":"Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor","volume":"8","author":"Walzer","year":"2007","journal-title":"Nat Immunol"},{"key":"2026060306164300700_aanag017-B11","doi-asserted-by":"publisher","first-page":"e20220551","DOI":"10.1084\/jem.20220551","article-title":"Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting Fc\u03b5RI\u03b3 expression","volume":"219","author":"Shemesh","year":"2022","journal-title":"J Exp Med"},{"key":"2026060306164300700_aanag017-B12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/TP.0000000000002450","article-title":"NKG2C natural killer cells in bronchoalveolar lavage are associated with cytomegalovirus viremia and poor outcomes in lung allograft recipients","volume":"103","author":"Calabrese","year":"2019","journal-title":"Transplantation"},{"key":"2026060306164300700_aanag017-B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajt.2022.10.006","article-title":"CD16(+) natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction","volume":"23","author":"Calabrese","year":"2023","journal-title":"Am J Transplant"},{"key":"2026060306164300700_aanag017-B14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fimmu.2019.01208","article-title":"FCGR3A and FCGR2A genotypes differentially impact allograft rejection and patients\u2019 survival after lung transplant","volume":"10","author":"Paul","year":"2019","journal-title":"Front Immunol"},{"key":"2026060306164300700_aanag017-B15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.healun.2022.10.014","article-title":"The \u00adhuman cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients","volume":"42","author":"Vietzen","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2026060306164300700_aanag017-B17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1164\/rccm.202303-0472OC","article-title":"MICB genomic variant is associated with NKG2D-mediated acute lung injury and death","volume":"209","author":"Aguilar","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060306164300700_aanag017-B18","doi-asserted-by":"publisher","first-page":"e164603","DOI":"10.1172\/jci.insight.164603","article-title":"NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes","volume":"7","author":"Calabrese","year":"2022","journal-title":"JCI Insight"},{"key":"2026060306164300700_aanag017-B19","doi-asserted-by":"publisher","first-page":"2302171","DOI":"10.1183\/13993003.02171-2023","article-title":"CD94+ natural killer cells potentiate pulmonary ischemia-reperfusion injury","volume":"64","author":"Tsao","year":"2024","journal-title":"Eur Respir J"},{"key":"2026060306164300700_aanag017-B20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"key":"2026060306164300700_aanag017-B21","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res"},{"key":"2026060306164300700_aanag017-B22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"2026060306164300700_aanag017-B23","doi-asserted-by":"publisher","first-page":"105459","DOI":"10.1016\/j.ebiom.2024.105459","article-title":"B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies","volume":"110","author":"Lee","year":"2024","journal-title":"EBioMedicine"},{"key":"2026060306164300700_aanag017-B24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood-2013-01-481705","article-title":"Induction of B7-H6, a ligand for the natural killer cell\u2013activating receptor NKp30, in inflammatory conditions","volume":"122","author":"Matta","year":"2013","journal-title":"Blood"},{"key":"2026060306164300700_aanag017-B25","doi-asserted-by":"publisher","first-page":"e157865","DOI":"10.1172\/jci.insight.157865","article-title":"Tissue-localized \u00adimmune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection","volume":"7","author":"Hayes","year":"2022","journal-title":"JCI Insight"},{"key":"2026060306164300700_aanag017-B26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060306164300700_aanag017-B27","doi-asserted-by":"publisher","first-page":"e92773","DOI":"10.1371\/journal.pone.0092773","article-title":"Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"2026060306164300700_aanag017-B28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41588-021-00889-w","article-title":"Genome-scale screens identify factors regulating tumor cell responses to natural killer cells","volume":"53","author":"Sheffer","year":"2021","journal-title":"Nat Genet"},{"key":"2026060306164300700_aanag017-B29","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3389\/fimmu.2019.02879","article-title":"Genome-wide CRISPR screen reveals cancer cell resistance to NK cells induced by NK-derived IFN-\u03b3","volume":"10","author":"Zhuang","year":"2019","journal-title":"Front Immunol"},{"key":"2026060306164300700_aanag017-B30","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.isci.2020.101709","article-title":"FcR\u03b3 gene editing reprograms conventional NK cells to display key features of adaptive human NK cells","volume":"23","author":"Liu","year":"2020","journal-title":"iScience"},{"key":"2026060306164300700_aanag017-B31","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf284","article-title":"Fc\u025bR1\u03b3-based activating chimeric antigen receptors enhanced natural killer cell function against HLA-E+ cells [manuscript published online ahead of print November 2, 2025]","author":"Lanier","year":"2025","journal-title":"J Immunol"},{"key":"2026060306164300700_aanag017-B32","doi-asserted-by":"publisher","first-page":"e20212434","DOI":"10.1084\/jem.20212434","article-title":"Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion","volume":"219","author":"Shemesh","year":"2022","journal-title":"J Exp Med"},{"key":"2026060306164300700_aanag017-B33","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"2026060306164300700_aanag017-B34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/s1074-7613(00)80574-9","article-title":"Association of DAP12 with activating CD94\/NKG2C NK cell receptors","volume":"8","author":"Lanier","year":"1998","journal-title":"Immunity"},{"key":"2026060306164300700_aanag017-B35","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verges","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060306164300700_aanag017-B36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat Immunol"},{"key":"2026060306164300700_aanag017-B37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.celrep.2016.04.005","article-title":"Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans","volume":"15","author":"Liu","year":"2016","journal-title":"Cell Rep"},{"key":"2026060306164300700_aanag017-B38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"2026060306164300700_aanag017-B39","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.healun.2024.02.007","article-title":"Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression","volume":"43","author":"Calabrese","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B40","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.healun.2025.03.010","article-title":"Persistent and progressive acute lung allograft dysfunction is linked to cell compositional and transcriptional changes in small \u00adairways","volume":"44","author":"Brunet-Ratnasingham","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/ajt.16293","article-title":"Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature","volume":"21","author":"Dugger","year":"2021","journal-title":"Am J Transplant"},{"key":"2026060306164300700_aanag017-B42","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.healun.2024.07.010","article-title":"Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality","volume":"43","author":"Mohanty","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/imcb.12230","article-title":"Widespread alterations of the peripheral blood innate immune cell profile in cystic fibrosis reflect lung pathology and may inform patient management","volume":"97","author":"Mulcahy","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"2026060306164300700_aanag017-B44","doi-asserted-by":"publisher","first-page":"814312","DOI":"10.3389\/fonc.2022.814312","article-title":"B7H6 serves as a negative prognostic marker and an immune modulator in human pancreatic cancer","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Oncol"},{"key":"2026060306164300700_aanag017-B45","doi-asserted-by":"publisher","first-page":"e1001224","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology"},{"key":"2026060306164300700_aanag017-B46","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Ggroup","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med"},{"key":"2026060306164300700_aanag017-B47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026060306164300700_aanag017-B48","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.4049\/jimmunol.2100970","article-title":"Multifunctional NK cell\u2013engaging antibodies targeting EGFR and NKp30 elicit efficient tumor cell killing and proinflammatory cytokine release","volume":"209","author":"Klausz","year":"2022","journal-title":"J Immunol"},{"key":"2026060306164300700_aanag017-B49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat Comm"},{"key":"2026060306164300700_aanag017-B50","doi-asserted-by":"publisher","first-page":"eadj7970","DOI":"10.1126\/sciimmunol.adj7970","article-title":"The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance","volume":"9","author":"Kilian","year":"2024","journal-title":"Sci Immunol"},{"key":"2026060306164300700_aanag017-B51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4049\/jimmunol.1501102","article-title":"Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production","volume":"196","author":"Salimi","year":"2016","journal-title":"J Immunol"},{"key":"2026060306164300700_aanag017-B52","doi-asserted-by":"publisher","first-page":"e1010325","DOI":"10.1371\/journal.ppat.1010325","article-title":"Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H","volume":"18","author":"Feehan","year":"2022","journal-title":"PLoS Pathog"},{"key":"2026060306164300700_aanag017-B53","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00363-20","article-title":"Pseudomonas aeruginosa infection impairs NKG2D-dependent NK cell cytotoxicity through regulatory T-cell activation","volume":"88","author":"Vourc\u2019h","year":"2020","journal-title":"Infect Immun"},{"key":"2026060306164300700_aanag017-B54","doi-asserted-by":"publisher","first-page":"e1000561","DOI":"10.1371\/journal.ppat.1000561","article-title":"Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis","volume":"5","author":"Chung","year":"2009","journal-title":"PLoS Pathog"},{"key":"2026060306164300700_aanag017-B55","doi-asserted-by":"publisher","first-page":"1242381","DOI":"10.3389\/fimmu.2023.1242381","article-title":"Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation","volume":"14","author":"Wellems","year":"2023","journal-title":"Front Immunol"},{"key":"2026060306164300700_aanag017-B56","doi-asserted-by":"publisher","first-page":"e60144","DOI":"10.1371\/journal.pone.0060144","article-title":"Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition","volume":"8","author":"Meehan","year":"2013","journal-title":"PLoS One"},{"key":"2026060306164300700_aanag017-B57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1164\/rccm.201906-1113OC","article-title":"Lung innate lymphoid cell composition is altered in primary graft dysfunction","volume":"201","author":"Monticelli","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060306164300700_aanag017-B58","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.healun.2013.10.022","article-title":"A new classification system for chronic lung allograft dysfunction","volume":"33","author":"Verleden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2026060306164300700_aanag017-B60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.201206-1025OC","article-title":"Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome","volume":"187","author":"Greenland","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060306164300700_aanag017-B61","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ajt.12630","article-title":"Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection","volume":"14","author":"Greenland","year":"2014","journal-title":"Am J Transplant"},{"key":"2026060306164300700_aanag017-B62","doi-asserted-by":"publisher","first-page":"e13332","DOI":"10.1111\/ctr.13332","article-title":"Genotypes associated with tacrolimus pharmacokinetics impact clinical outcomes in lung transplant recipients","volume":"32","author":"Calabrese","year":"2018","journal-title":"Clin Transplant"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag017\/66865389\/aanag017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/6\/741\/66865389\/aanag017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/6\/741\/66865389\/aanag017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:16:48Z","timestamp":1780481808000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/74\/6\/741\/8475392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,12]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajrcmb\/aanag017","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,2,12]]}}}